Allergy/Imm Medical News about asthma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids
Allergy and Asthma Proceedings, 07/01/09

Berger WE et al. - All treatments reduced albuterol use and nighttime awakenings and improved asthma symptom scores; these improvements were greater for CIC80 b.i.d. than for placebo. The incidence of adverse events was similar among treatment groups. In this study, CIC80 b.i.d. improved disease control in subjects with mild-to-moderate persistent asthma not using an ICS and provided greater improvements than CIC160 q.d.

<< Previous
Procaterol Potentiates the Anti-Inflammatory Activity of...

Next >>
The NanA neuraminidase of Streptococcus pneumoniae is involved in...